and other data for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Scientists find alternative routes to market
Foundations are making a mark in Denmark’s pharma sector
Big pharma is a shrinking business
Cutting costs proves easier than generating growth